Japan to Receive 1.6 Million Courses of MSD’s COVID-19 Drug

Health Minister Shigeyuki Goto The Japanese government has clinched a supply agreement with MSD to receive 1.6 million courses of the company’s oral COVID-19 drug molnupiravir, if it is successfully approved, the drug maker and Health Minister Shigeyuki Goto said...read more